Skip to content
Insider tapeLive · 5:07 PM ET
My stocks

Daniel J. Starks

At a glance: Daniel J. Starks is Director at Abbott Laboratories (ABT). Their latest SEC Form 4, filed Apr 28, 2026, reported a purchase of $927K. On file: 3 purchase lines ($2.0M) and 0 sale lines ($0).

Disclosed holdings: about $703M of ABT stock: 6,751,103 shares reported on their latest Form 4 (filed Apr 28, 2026), valued at the Nov 20, 2026 close of $104.17. This counts only ABT shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.

Director at Abbott Laboratories (ABT)

Purchase track record

Below average. Based on 2 purchases with a full 90 days of price history.

35
Avg. 90-day return-4.4%
vs. S&P 500-9.6%
Beat the market50%
Paper profit on buys+$70K
Total bought / sold$2.0M / $0

Daniel J. Starks's InsiderPrint

3 trades from SEC Form 4 filings, 2026 to 2026, drawn as one fingerprint.

InsiderPrint of Daniel J. Starks: 3 trades, 2026 to 20262026: 3 buys, 0 sales

Reading this print: Almost only buys, trading about 3 times a year, typically $545K a trade.

  • Bump outward: a purchase (3)
  • Dent inward: a sale (0)
  • One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.

Insiders with a similar print

  1. David R. McAtee IIDirector · ADM · 100% match
  2. Kurt HalleadVp-Treasurer & Ir · TTI · 98% match
  3. Richard Scott YoungCEO, President · IAUX · 98% match
  4. Caspar Felix CoppettiCEO · ONON · 97% match
  5. Olivier BernhardExecutive Officer · ONON · 97% match

Matched on seven traits of each insider's trading pattern (buy share, pace, typical size, planned sales, seasonality, buying after drops, number of companies). Pattern matching on public filings; history, not a prediction.

Every purchase since 2026

From the SEC's insider data sets: each open-market buy by Daniel J. Starks, matched to how the stock did over the next 90 days against the S&P 500.

1 of 2 buys beat the S&P 500 (50%), median -9.6% vs. the index. Small sample: treat with care. All insider buys: 46%.

StockFiled90 days vs. S&P 500
ABTApr 28, 2026+8.0%
ABTFeb 6, 2026-27.2%

Buys made close together in one stock count once. Price-only returns; history, not a prediction.

Reported trades

Filed Stock Type Shares Price Value Since
Apr 28SEC ABTAbbott LaboratoriesPast buys 1/2 beat S&P Buy 10,0006,751,103 held (+0%) $92.65 $927K +12.4%
Feb 6SEC ABTAbbott LaboratoriesFirst buyPast buys 1/2 beat S&P Buy 4,9676,733,784 held (+0%) $109.14 $542K -4.6%
Feb 6SEC ABTAbbott LaboratoriesFirst buyPast buys 1/2 beat S&P Buy 5,0336,738,817 held (+0%) $108.33 $545K -3.8%
  • Buy

    Director Daniel J Starks bought $927K of ABT at $92.65 — largest purchase by this insider in our records.

  • Buy

    Director Daniel J Starks bought $542K of ABT at $109.14 — first open-market purchase in our records.

Follow Daniel J. Starks

Get one email when Daniel J. Starks files a new purchase or sale. Free.

At most one email a day about Daniel J. Starks, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.